66298-49-5 Usage
General Description
4,6-DIIODO-2-METHYLPYRIMIDINE is a chemical compound with the molecular formula C5H4I2N2. It is a pyrimidine derivative with two iodine atoms and a methyl group attached to the second and sixth carbon atoms of the pyrimidine ring. 4,6-DIIODO-2-METHYLPYRIMIDINE is commonly used in organic synthesis as a reagent for various chemical transformations, especially in the preparation of pharmaceuticals and agrochemicals. It is known for its high reactivity and ability to undergo substitution and coupling reactions, making it a versatile building block in the synthesis of complex organic molecules. Additionally, 4,6-DIIODO-2-METHYLPYRIMIDINE is also used in the production of dyes, pigments, and other specialty chemicals. However, it is important to handle this compound with caution due to its potentially hazardous properties, including its toxic and irritant effects.
Check Digit Verification of cas no
The CAS Registry Mumber 66298-49-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,6,2,9 and 8 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 66298-49:
(7*6)+(6*6)+(5*2)+(4*9)+(3*8)+(2*4)+(1*9)=165
165 % 10 = 5
So 66298-49-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H4I2N2/c1-3-8-4(6)2-5(7)9-3/h2H,1H3
66298-49-5Relevant articles and documents
COMPOUNDS FOR INHIBITING LRRK2 KINASE ACTIVITY
-
Page/Page column 46; 57; 58, (2018/09/08)
Compounds of Formula (I) or pharmaceutically acceptable salt thereof, a pharmaceutical compositions comprising these compounds, the use of these compounds and compositions in the treatment of diseases in which LRRK-2 kinase is involved.
COMPOUNDS
-
Page/Page column 61, (2018/08/20)
Provided are novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, compositions containing them and their use in the treatment of or prevention of diseases associated with or characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).
COMPOUNDS
-
Page/Page column 52; 78, (2018/08/20)
The present invention provides novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, compositions containing them and their use in the treatment of or prevention of diseases associated with or characterized by LRRK2 kinase a
